PlaqueTec is at the forefront of healthcare technology, developing innovative biomarker-based strategies for personalized medicine. Utilizing a novel Liquid Biopsy System, the company aims to revolutionize the prevention, diagnosis, and treatment of Coronary Artery Disease, a leading global health challenge.